AzTrials
AzTrials

Contraception10-053NCT01192490

Topical Lidocaine on the Cervix and Intra-Cervical Prior to Insertion of Intrauterine Devices

A study testing Lidocaine and Lubricant in people with Contraception, run by University of Tennessee at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The hypothesis of this study is that topical cervical and intra-cervical lidocaine will decrease pain associated with the insertion of a Mirena® (levonorgestrel intrauterine device). 1. Read more about this study

Who is it for?
Any age, women onlyHealthy volunteers can take part
Conditions the study is for
Contraception
What is being tested?
Lidocaine and Lubricant
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
210 participants
Where
1 siteUnited States
Study dates
Aug 2010to Dec 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Any subject receiving a Mirena® (levonorgestrel intrauterine device) for standard indications.
  • Subjects who received nonsteroidal anti-inflammatory drugs (NSAIDS) will not be excluded.

Who cannot join

  • Subjects do not desire to be involved in the study
  • Subjects who have taken narcotics.
  • If the Mirena® (levonorgestrel intrauterine device) is not able to be successfully placed.
  • If cervical dilation is required, these subjects will be placed in a separate subset and will be reported on separately.
  • Subject has allergy to lidocaine.

Trial locations and contacts

1 site in 1 country.

Ben Moore, MD contact

423-778-7515

benatmc@hotmail.com

Brett Bryant, MD contact

423-778-7515

bryant_brett@hotmail.com

United States1 site, 1 recruiting
  • University of Tennessee Chattanooga Department of Obstetrics and Gynecology

    Chattanooga, Tennessee, 37403

    Ben Moore, MD, 423-778-2580, benatmc@hotmail.com

    Brett Bryant, MD, 423-778-7515, brett_bryant@hotmail.com

    Recruiting

Other trials in United States

About this study

The hypothesis of this study is that topical cervical and intra-cervical lidocaine will decrease pain associated with the insertion of a Mirena® (levonorgestrel intrauterine device).

  1. Primary Aim- Determine if topical lidocaine intra-cervically and on the cervix decreases the pain associated with insertion of a Mirena® (levonorgestrel intrauterine device).
Read the detailed description

There have been multiple studies performed to determine a medication that will decrease the pain associated with intrauterine device insertion. These studies have tested the use of misoprostol as well as NSAIDS to determine if these decrease the pain associated with insertion. There has also been one small, poorly performed, study that tested the use of intracervical topical lidocaine prior to IUD insertion. Misoprostol and NSAIDS were found to be non-efficacious in decreasing pain. Topical lidocaine was shown to be effective, however, secondary to this being a poorly performed study, additional studies are needed. This study is to determine if topical lidocaine does indeed decrease the pain associated with insertion of the Mirena® (levonorgestrel intrauterine device).

This is a double blinded experimental study to determine whether or not topical lidocaine gel applied to the cervix and intra-cervically decreases pain associated with insertion of the Mirena® (levonorgestrel intrauterine device). Subjects will be randomized into two groups. One group will receive 2% lidocaine gel on the cervix and intra-cervically. The other group will receive a placebo, which will consist of KY being placed on the cervix and intra-cervically. After the Mirena® (levonorgestrel intrauterine device) is inserted, each subject's pain will be assessed by using a visual analog pain scale, and their response will be recorded on the information form. This pain scale will be assessed at the time of insertion, five minutes after insertion, and ten minutes after insertion. The only other study that researched the use of topical lidocaine prior to insertion of an IUD only recorded a pain scale at the time of insertion. Additional scores will be recorded at five and ten minutes to determine if pain is reduced in those time periods. These time periods have been chosen in order that all of this information can be recorded during a normal office visit. A visual analog pain scale is the scale included which measures pain on a scale of zero to ten with zero being no pain at all and ten being the worst pain of your life. This pain scale will be a scale ranging from zero to ten with faces depicting the amount of pain involved for each score. Since there will be different physicians placing the intrauterine devices, there will be a protocol on how to perform the insertion in an attempt to make all insertions as uniform as possible. A copy of this protocol has been included.

Conditions
Contraception
Being tested
Lidocaine, Lubricant

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • LidocaineDrug

    Also called Mirena

    5cc of 2% Lidocaine gel will be placed on the cervix and intra-cervically prior to placement of a Mirena

  • LubricantDrug

    Also called KY gel

    KY Gel will be placed on the cervix and intra-cervically prior to placement of the Mirena

Study groups in NCT01192490
Study groupRoleWhat they receive
Lidocaine ArmExperimentalThis arm will receive intracervical and cervical lidocaine prior to placement of a Mirena.
Receives: Drug: Lidocaine
LubricantPlacebo comparatorSubjects in this arm will receive KY gel intracervically and on the cervix prior to placement of a Mirena.
Receives: Drug: Lubricant

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Determine if topical lidocaine intra-cervically and on the cervix decreases the pain associated with insertion of a Mirena® (levonorgestrel intrauterine device).

    In order to analyze the data, pain scores will be stratified into three different categories. These categories will be as follows: visual analog scale (VAS) score of 0-2, VAS score of 2-4, VAS score of 5 and greater. This will allow an odds ratio to be calculated and the use of a Chi Square analysis.

    Measured: 2-3yrs

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Sep 2010 (estimated)
  2. Study startAug 2010
  3. Primary completionSep 2012 (estimated)
  4. Study completionDec 2012 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
210 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01192490
Sponsor's protocol ID
00002301
Acronym
10-053
Status last verified
Jun 2011
First submitted
26 Aug 2010
Last updated
16 Jun 2011
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Lidocaine and Lubricant in people with Contraception, run by University of Tennessee at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Jun 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ben Moore, MD (423-778-7515, benatmc@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Determine if topical lidocaine intra-cervically and on the cervix decreases the pain associated with insertion of a Mirena® (levonorgestrel intrauterine device). (time frame: 2-3yrs). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jun 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in